Showing results (1011-1020 of 11,545) with videos related to

Sort By:
Pageof 1,155
British Journal of Clinical Pharmacology|December 21, 2016
Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infantsJin A Sohn, Han-Suk Kim, Jaeseong Oh, et al.
British Journal of Clinical Pharmacology|August 1, 1989
Effect of diclofenac on prostaglandin E and hyaluronic acid production by human synovial fibroblasts stimulated with interleukin-1F A Meyer, I Yaron, V Mashiah, et al.
British Journal of Clinical Pharmacology|October 22, 2016
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Eva Germovsek, Charlotte I S Barker, Mike Sharland, et al.
British Journal of Clinical Pharmacology|October 26, 2016
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 studyArne Ring, Tom Morris, Marcin Wozniak, et al.
British Journal of Clinical Pharmacology|May 8, 2014
Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover studyTimo Siepmann, Denise Heinke, Jessica Kepplinger, et al.
British Journal of Clinical Pharmacology|November 19, 2016
First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasisSophie Glatt, Eric Helmer, Birgit Haier, et al.
British Journal of Clinical Pharmacology|October 14, 2016
Spironolactone use and risk of incident cancers: a retrospective, matched cohort studyIsla S Mackenzie, Steven V Morant, Li Wei, et al.
British Journal of Clinical Pharmacology|February 11, 2017
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patientsYasuhiro Tsuji, Nicholas H G Holford, Hidefumi Kasai, et al.
British Journal of Clinical Pharmacology|February 5, 2017
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacyMichael Paulzen, Ekkehard Haen, Christoph Hiemke, et al.
Pageof 1,155